Parents Using Cannabis for Their Children's Epilepsy See Themselves as Scientific Experimenters, Not Alternative Medicine Rebels | Research

The takeaway

Interviews with 25 Southern California parents using cannabis for pediatric epilepsy revealed they viewed their efforts as aligned with scientific methods and wanted biomedical legitimacy, not rejection of conventional medicine.

Parents considering cannabis for their child's epilepsy.

Parents described systematic dose tracking and seizure monitoring as aligned with scientific methods

What the researchers found

Twenty-five parents who used, had used, or sought to use cannabis for their children's epilepsy were interviewed about their evidentiary standards, research methods, and aims.

Contrary to stereotypes of alternative medicine users rejecting science, these parents generally described their work as experimentation. They saw their careful tracking of doses, seizure counts, and side effects as adhering to scientific practices, and they viewed their individual-patient data as contributing to the broader medical cannabis knowledge base.

The parents did not reject biomedicine. Instead, they were driven by biomedical dependency (their children required ongoing medical care), high caregiver burden (managing intractable seizures), and a deep desire for their children's biomedical "demarginalization," meaning they wanted their children's cannabis use to be recognized and supported within the medical system rather than forced to exist outside it.

This collaborative stance toward medicine, combined with the practical demands of managing a child's uncontrolled seizures, produced a form of lay research that both challenged and reinforced the boundaries between expert and non-expert knowledge.

Why it matters

Parents of children with intractable epilepsy are often portrayed as either desperate science-deniers or brave pioneers. This study complicates both narratives: these parents are embedded in the medical system, want scientific legitimacy, and approach cannabis treatment with methodical rigor. Understanding their perspective can help clinicians engage more productively with families using cannabis for pediatric epilepsy.

The numbers in context

25 parents in Southern California. All had children with intractable epilepsy. Parents described systematic dose tracking and seizure monitoring. None rejected biomedicine entirely.

How the study worked

Qualitative interview study of 25 Southern California parents in 2016. Semi-structured interviews explored evidentiary standards, research practices, and attitudes toward biomedical science in the context of pediatric cannabis use for epilepsy.

What this study cannot tell us

Small qualitative sample from one geographic area. Parents willing to be interviewed about cannabis use may be more articulate and confident than those who are not. The study focused on parents' self-descriptions of their methods, not on whether those methods actually produced reliable evidence. Selection bias toward parents who found cannabis helpful enough to continue.

How to read the evidence

Preliminary evidence from a small qualitative study in one region.

When this study was published

Published in 2017, before FDA approval of Epidiolex in 2018.

The bigger picture

This study captures a moment in the medicalization of cannabis, when parents were forced to become their own researchers because the medical system could not help them. The subsequent FDA approval of Epidiolex (2018) partially addressed this gap, but the parent-researcher phenomenon reflects a broader pattern in which patient communities drive drug development when institutional medicine moves too slowly.

Questions still open

Has the FDA approval of Epidiolex changed parent attitudes toward using unregulated cannabis products? How should clinicians engage with parents' self-experimentation data? Can patient-generated evidence be systematically collected and analyzed to contribute to medical knowledge?

Common questions

Are parents who use cannabis for their children's epilepsy anti-science?

This study found the opposite. Parents described their approach as scientific experimentation, carefully tracking doses and seizure outcomes. They wanted their efforts to be recognized within the medical system, not outside it. They used cannabis because conventional treatments had failed, not because they rejected conventional medicine.

How do parents manage cannabis treatment for epilepsy without medical guidance?

Parents in this study described systematic approaches including dose tracking, seizure diaries, and trial-and-error with different products and doses. They often relied on other parent networks, online communities, and their own observations. Many expressed frustration at having to manage this largely on their own.

Read the original research

Parent use of cannabis for intractable pediatric epilepsy: Everyday empiricism and the boundaries of scientific medicine.

Social science & medicine (1982), 190, 190-198

View on PubMed ↗Publisher’s paper ↗

Citation

Sobo, Elisa J. (2017). Parent use of cannabis for intractable pediatric epilepsy: Everyday empiricism and the boundaries of scientific medicine.. Social science & medicine (1982), 190, 190-198. https://doi.org/10.1016/j.socscimed.2017.08.003